December 1, 2022

Orthopedic Implants Market Size to Hit Around US$ 72.1 billion by 2030

Precedence Research a new report on orthopedic implants market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the market’s future. The global orthopedic implants market size was valued at US$ 47.8 billion in 2021. The global orthopedic implants market is projected to reach US$ 72.1 billion by 2030, registering a compound annual growth rate (CAGR) of 4.67% during the forecast period from 2022 to 2030.

Orthopedic Implants Market

Download Free Sample Copy with [email protected] https://www.precedenceresearch.com/sample/1884

The global orthopedic implants market report offers various segments analysis by size, trends, growth factors, opportunities and key country outlook to 2030. The report offers a detailed analysis and information as per orthopedic implants, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Orthopedic Implants Market Report Scope 
Report Coverage Details
Market Size by 2030 USD 72.1 Billion
Growth Rate from 2022 to 2030 CAGR of 4.67%
North America Market Share in 2021 42.5%
Metallic Biomaterials Segment Market Share in 2021 58%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Type, Biomaterial, Procedure, End User, Geography

The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Read [email protected] High Speed Engine Market Size to Hit Around US$ 57.4 billion by 2030

Some of the prominent players in the orthopedic implants market include:
  • Zimmer Biomet Holdings
  • Stryker Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • NuVasive
  • Arthrex, Inc.
  • DJO Finance LLC
  • Smith and Nephew Plc.
  • CONMED Corporation.
Orthopedic Implants Market Segmentation

By Product

  • Reconstructive Joint Replacements
    • Knee Replacement Implants
    • Hip Replacement Implants
    • Extremities
      • Upper Extremity Reconstruction
        • Elbow
        • Shoulder
        • Hand Wrist
      • Lower Extremity Reconstruction
        • Upper
        • Lower
  • Spinal Implants
    • Spinal Fusion Implants
      • Thoracolumbar Devices
      • Cervical Fixation Devices
      • Interbody Fusion Devices
    • Vertebral Compression Fracture (VCF) Devices
      • Balloon Kyphoplasty Devices
      • Vertebroplasty Devices
    • Motion Preservation Devices/Non-Fusion Devices
      • Dynamic Stabilization Devices
      • Artificial Disc Replacement Devices
      • Annulus Repair Devices
      • Nuclear Disc Prostheses
  • Dental Implants
    • Root Form Dental Implants
    • Plate Form Dental Implants
  • Trauma
  • Orthobiologics
    • Demineralized Bone Matrix (DBM)
    • Allograft
    • Bone Morphogenetic Protein (BMP)
    • Viscosupplementation Products
    • Synthetic Bone Substitutes
    • Others
  • Others

By Type

  • Wrist & Shoulder
  • Dental
  • Knee
  • Hip
  • Spine
  • Ankle

By Biomaterial

  • Metallic Biomaterials
    • Stainless Steel
    • Titanium Alloy
    • Cobalt Alloy
    • Others
  • Ceramic Biomaterials
  • Polymers Biomaterials
  • Others

By Procedure

  • Open Surgery
  • Minimally Invasive Surgery (MIS)
  • Others

By End User

  • Hospitals
  • Orthopedic Clinics
  • Home Cares
  • Others

Regional Segmentation

  • Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
  • Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
  • North America [United States, Canada, Mexico]
  • South America [Brazil, Argentina, Columbia, Chile, Peru]
  • Middle East & Africa [GCC, North Africa, South Africa]

Key Questions are

  • What are the key factors influencing the orthopedic implants market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2022 and 2030?
  • What would be the Y-o-Y growth trend of the global market between 2022 and 2030?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

Research Objectives and Research Approach

The comprehensive report on the global orthopedic implants market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global orthopedic implants market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global orthopedic implants market in terms of type, application, region and others. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global market.

Why should you invest in this report?

If you are aiming to enter the global orthopedic implants market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for orthopedic implants are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Orthopedic Implants Market 

5.1. COVID-19 Landscape: Orthopedic Implants Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Orthopedic Implants Market, By Product

8.1. Orthopedic Implants Market, by Product, 2022-2030

8.1.1. Reconstructive Joint Replacements

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Spinal Implants

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Dental Implants

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Trauma

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Orthobiologics

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Orthopedic Implants Market, By Type

9.1. Orthopedic Implants Market, by Type, 2022-2030

9.1.1. Wrist & Shoulder

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dental

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Knee

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Hip

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Spine

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Ankle

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Orthopedic Implants Market, By Biomaterial 

10.1. Orthopedic Implants Market, by Biomaterial, 2022-2030

10.1.1. Metallic Biomaterials

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Ceramic Biomaterials

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Polymers Biomaterials

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Orthopedic Implants Market, By Procedure

11.1. Orthopedic Implants Market, by Procedure, 2022-2030

11.1.1. Open Surgery

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Minimally Invasive Surgery (MIS)

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Orthopedic Implants Market, By End User

12.1. Orthopedic Implants Market, by End User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Orthopedic Clinics

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Home Cares

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Orthopedic Implants Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.7. Market Revenue and Forecast, by End User (2017-2030)

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.5. Market Revenue and Forecast, by End User (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.7. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.8. Market Revenue and Forecast, by End User (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.10. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Zimmer Biomet Holdings

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Stryker Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Johnson & Johnson

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Medtronic Plc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. NuVasive

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Arthrex, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. DJO Finance LLC

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Smith and Nephew Plc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. CONMED Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Buy This Premium Research Report Click [email protected] https://www.precedenceresearch.com/checkout/1884

Our Press [email protected] https://www.precedenceresearch.com/press-releases

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: [email protected]

Website: https://www.precedenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *